The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) insider Julie Tankard acquired 1,022 shares of The Biotech Growth Trust stock in a transaction on Wednesday, December 4th. The stock was acquired at an average cost of GBX 972 ($12.35) per share, for a total transaction of £9,933.84 ($12,622.41).
The Biotech Growth Trust Stock Down 1.9 %
BIOG stock traded down GBX 18 ($0.23) during mid-day trading on Thursday, hitting GBX 940 ($11.94). 53,008 shares of the company were exchanged, compared to its average volume of 71,241. The firm has a market cap of £302.02 million, a P/E ratio of 458.65 and a beta of 0.50. The Biotech Growth Trust PLC has a 1-year low of GBX 761 ($9.67) and a 1-year high of GBX 1,068.36 ($13.58). The firm's 50 day simple moving average is GBX 999.44 and its 200 day simple moving average is GBX 999.44. The company has a debt-to-equity ratio of 13.03, a quick ratio of 0.00 and a current ratio of 0.33.
About The Biotech Growth Trust
(
Get Free Report)
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.
Featured Articles
Before you consider The Biotech Growth Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.
While The Biotech Growth Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.